- Cash receipts from customers $298k (up from previous quarter $273K)
- soft launch of Company's plant-based skincare products scheduled for November 2021 at the Hemp, Health and Innovation Expo
- Company's first order of Canntab's cannabinoid hard pill formulations has been received
- Western Sydney University has completed the first draft clinical trial protocol